152 related articles for article (PubMed ID: 21035497)
41. Glioblastoma tumor initiating cells: therapeutic strategies targeting apoptosis and microRNA pathways.
Liu J; Albrecht AM; Ni X; Yang J; Li M
Curr Mol Med; 2013 Mar; 13(3):352-7. PubMed ID: 23331007
[TBL] [Abstract][Full Text] [Related]
42. Deconstructing mTOR complexes in regulation of Glioblastoma Multiforme and its stem cells.
Jhanwar-Uniyal M; Jeevan D; Neil J; Shannon C; Albert L; Murali R
Adv Biol Regul; 2013 May; 53(2):202-10. PubMed ID: 23231881
[TBL] [Abstract][Full Text] [Related]
43. Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma.
Barzegar Behrooz A; Talaie Z; Jusheghani F; Łos MJ; Klonisch T; Ghavami S
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163279
[TBL] [Abstract][Full Text] [Related]
44. Crosstalk between PI3K/AKT/mTOR and WNT/β-Catenin signaling in GBM - Could combination therapy checkmate the collusion?
Daisy Precilla S; Biswas I; Kuduvalli SS; Anitha TS
Cell Signal; 2022 Jul; 95():110350. PubMed ID: 35525406
[TBL] [Abstract][Full Text] [Related]
45. PI3K/Akt/mTOR signaling pathway in cancer stem cells.
Karami Fath M; Ebrahimi M; Nourbakhsh E; Zia Hazara A; Mirzaei A; Shafieyari S; Salehi A; Hoseinzadeh M; Payandeh Z; Barati G
Pathol Res Pract; 2022 Sep; 237():154010. PubMed ID: 35843034
[TBL] [Abstract][Full Text] [Related]
46. The PI3K-Akt pathway promotes microtubule stabilization in migrating fibroblasts.
Onishi K; Higuchi M; Asakura T; Masuyama N; Gotoh Y
Genes Cells; 2007 Apr; 12(4):535-46. PubMed ID: 17397400
[TBL] [Abstract][Full Text] [Related]
47. [The PI3K-AKT-mTOR pathway as a target in cancer therapeutics].
Hirao A
Nihon Rinsho; 2012 Nov; 70 Suppl 8():57-62. PubMed ID: 23513812
[No Abstract] [Full Text] [Related]
48. Metabolic Reprogramming by the PI3K-Akt-mTOR Pathway in Cancer.
Lien EC; Lyssiotis CA; Cantley LC
Recent Results Cancer Res; 2016; 207():39-72. PubMed ID: 27557534
[TBL] [Abstract][Full Text] [Related]
49. Signal Transduction Reaction Monitoring Deciphers Site-Specific PI3K-mTOR/MAPK Pathway Dynamics in Oncogene-Induced Senescence.
de Graaf EL; Kaplon J; Mohammed S; Vereijken LA; Duarte DP; Redondo Gallego L; Heck AJ; Peeper DS; Altelaar AF
J Proteome Res; 2015 Jul; 14(7):2906-14. PubMed ID: 26011226
[TBL] [Abstract][Full Text] [Related]
50. Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy.
Chang L; Graham PH; Hao J; Bucci J; Cozzi PJ; Kearsley JH; Li Y
Cancer Metastasis Rev; 2014 Sep; 33(2-3):469-96. PubMed ID: 24445654
[TBL] [Abstract][Full Text] [Related]
51. Targeted inhibition of dominant PI3-kinase catalytic isoforms increase expression of stem cell genes in glioblastoma cancer stem cell models.
Jones NM; Rowe MR; Shepherd PR; McConnell MJ
Int J Oncol; 2016 Jul; 49(1):207-16. PubMed ID: 27176780
[TBL] [Abstract][Full Text] [Related]
52. Efficacy of rapamycin against glioblastoma cancer stem cells.
Mendiburu-Eliçabe M; Gil-Ranedo J; Izquierdo M
Clin Transl Oncol; 2014 May; 16(5):495-502. PubMed ID: 24043497
[TBL] [Abstract][Full Text] [Related]
53. Proteomic Analysis of Human Endometrial Tissues Reveals the Roles of PI3K/AKT/mTOR Pathway and Tumor Angiogenesis Molecules in the Pathogenesis of Endometrial Cancer.
Liu Z; Hong Z; Qu P
Biomed Res Int; 2020; 2020():5273969. PubMed ID: 32908897
[TBL] [Abstract][Full Text] [Related]
54. Wnt/beta-catenin and PI3K/Akt/mTOR Signaling Pathways in Glioblastoma: Two Main Targets for Drug Design: A Review.
Shahcheraghi SH; Tchokonte-Nana V; Lotfi M; Lotfi M; Ghorbani A; Sadeghnia HR
Curr Pharm Des; 2020; 26(15):1729-1741. PubMed ID: 32003685
[TBL] [Abstract][Full Text] [Related]
55. Akt/mTOR signalling in myelination.
Norrmén C; Suter U
Biochem Soc Trans; 2013 Aug; 41(4):944-50. PubMed ID: 23863161
[TBL] [Abstract][Full Text] [Related]
56. Prospects for mTOR targeting in adult T cell leukemia.
Altman JK; Platanias LC
Leuk Lymphoma; 2009 Apr; 50(4):525-6. PubMed ID: 19373648
[No Abstract] [Full Text] [Related]
57. Signaling Pathways in Leukemic Stem Cells.
Gurska LM; Ames K; Gritsman K
Adv Exp Med Biol; 2019; 1143():1-39. PubMed ID: 31338813
[TBL] [Abstract][Full Text] [Related]
58. Correlation between telomerase and mTOR pathway in cancer stem cells.
Dogan F; Biray Avci C
Gene; 2018 Jan; 641():235-239. PubMed ID: 29074462
[TBL] [Abstract][Full Text] [Related]
59. Receptor tyrosine kinase-Ras-PI 3 kinase-Akt signaling network in glioblastoma multiforme.
Tuncel G; Kalkan R
Med Oncol; 2018 Aug; 35(9):122. PubMed ID: 30078108
[TBL] [Abstract][Full Text] [Related]
60. mTOR inhibition and adult T-cell leukemia.
Hirase C; Maeda Y; Yamaguchi T; Miyatake J; Kanamaru A
Leuk Lymphoma; 2009 Apr; 50(4):645-7. PubMed ID: 19373664
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
